Nomogram including indirect bilirubin for the prediction of post-stroke depression at 3 months after mild acute ischemic stroke onset. 2023

Yanyan Wang, and Wenzhe Sun, and Jinfeng Miao, and Zhou Zhu, and Wenwen Liang, and Xiuli Qiu, and Chensheng Pan, and Guo Li, and Yan Lan, and Xin Zhao, and Yi Xu
Department of Neurology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China.

Post-stroke depression (PSD) has been proven to be associated with stroke severity. Thus, we hypothesized that the prevalence of PSD would be lower in patients with mild stroke. We aim to explore predictors of depression at 3 months after mild acute ischemic stroke (MAIS) onset and to develop a practical and convenient prediction model for the early identification of patients at high risk. A total of 519 patients with MAIS were consecutively recruited from three hospitals in Wuhan city, Hubei province. MAIS was defined as a National Institute of Health Stroke Scale (NIHSS) score of ≤5 at admission. Meeting the DSM-V diagnostic criteria and a 17-item Hamilton Rating Scale for Depression (HAMD-17) score of >7 at their 3-month follow-up were considered the primary outcomes. A multivariable logistic regression model was used to determine the factors adjusted for potential confounders, and all independent predictors were brought into the construction of a nomogram to predict PSD. The prevalence of PSD is up to 32% at 3 months after MAIS onset. After adjusting for potential confounders, indirect bilirubin (p = 0.029), physical activity (p = 0.001), smoking (p = 0.025), hospitalization days (p = 0.014), neuroticism (p < 0.001), and MMSE (p < 0.001) remained independently and significantly related with PSD. The concordance index (C-index) of the nomogram jointly constructed by the aforementioned six factors was 0.723 (95% CI: 0.678-0.768). The prevalence of PSD seems equally high even if the ischemic stroke is mild, which calls for great concern from clinicians. In addition, our study found that a higher level of indirect bilirubin can lower the risk of PSD. This finding may provide a potential new approach to PSD treatment. Furthermore, the nomogram including bilirubin is convenient and practical to predict PSD after MAIS onset.

UI MeSH Term Description Entries

Related Publications

Yanyan Wang, and Wenzhe Sun, and Jinfeng Miao, and Zhou Zhu, and Wenwen Liang, and Xiuli Qiu, and Chensheng Pan, and Guo Li, and Yan Lan, and Xin Zhao, and Yi Xu
January 2021, Clinical interventions in aging,
Yanyan Wang, and Wenzhe Sun, and Jinfeng Miao, and Zhou Zhu, and Wenwen Liang, and Xiuli Qiu, and Chensheng Pan, and Guo Li, and Yan Lan, and Xin Zhao, and Yi Xu
November 2021, Journal of personalized medicine,
Yanyan Wang, and Wenzhe Sun, and Jinfeng Miao, and Zhou Zhu, and Wenwen Liang, and Xiuli Qiu, and Chensheng Pan, and Guo Li, and Yan Lan, and Xin Zhao, and Yi Xu
January 2020, Frontiers in psychiatry,
Yanyan Wang, and Wenzhe Sun, and Jinfeng Miao, and Zhou Zhu, and Wenwen Liang, and Xiuli Qiu, and Chensheng Pan, and Guo Li, and Yan Lan, and Xin Zhao, and Yi Xu
January 2022, Frontiers in aging neuroscience,
Yanyan Wang, and Wenzhe Sun, and Jinfeng Miao, and Zhou Zhu, and Wenwen Liang, and Xiuli Qiu, and Chensheng Pan, and Guo Li, and Yan Lan, and Xin Zhao, and Yi Xu
January 2022, Journal of the Academy of Consultation-Liaison Psychiatry,
Yanyan Wang, and Wenzhe Sun, and Jinfeng Miao, and Zhou Zhu, and Wenwen Liang, and Xiuli Qiu, and Chensheng Pan, and Guo Li, and Yan Lan, and Xin Zhao, and Yi Xu
October 2019, Journal of affective disorders,
Yanyan Wang, and Wenzhe Sun, and Jinfeng Miao, and Zhou Zhu, and Wenwen Liang, and Xiuli Qiu, and Chensheng Pan, and Guo Li, and Yan Lan, and Xin Zhao, and Yi Xu
January 2021, Neuropsychiatric disease and treatment,
Yanyan Wang, and Wenzhe Sun, and Jinfeng Miao, and Zhou Zhu, and Wenwen Liang, and Xiuli Qiu, and Chensheng Pan, and Guo Li, and Yan Lan, and Xin Zhao, and Yi Xu
June 2017, Medical science monitor : international medical journal of experimental and clinical research,
Yanyan Wang, and Wenzhe Sun, and Jinfeng Miao, and Zhou Zhu, and Wenwen Liang, and Xiuli Qiu, and Chensheng Pan, and Guo Li, and Yan Lan, and Xin Zhao, and Yi Xu
January 2013, PloS one,
Yanyan Wang, and Wenzhe Sun, and Jinfeng Miao, and Zhou Zhu, and Wenwen Liang, and Xiuli Qiu, and Chensheng Pan, and Guo Li, and Yan Lan, and Xin Zhao, and Yi Xu
January 2022, Frontiers in neurology,
Copied contents to your clipboard!